Wellington Management Group LLP lessened its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 19.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 323,047 shares of the health services provider's stock after selling 79,833 shares during the period. Wellington Management Group LLP owned 0.57% of Maximus worth $24,115,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Nordea Investment Management AB bought a new position in shares of Maximus in the fourth quarter worth $4,618,000. Fort Washington Investment Advisors Inc. OH lifted its holdings in Maximus by 39.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock worth $22,132,000 after purchasing an additional 83,390 shares in the last quarter. IFP Advisors Inc boosted its stake in Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after purchasing an additional 302 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in Maximus during the 4th quarter valued at about $1,113,000. Finally, Legato Capital Management LLC increased its position in shares of Maximus by 33.9% during the fourth quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock valued at $2,399,000 after buying an additional 8,138 shares during the period. Institutional investors own 97.21% of the company's stock.
Analysts Set New Price Targets
Several research analysts have commented on the stock. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a report on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.
View Our Latest Report on Maximus
Maximus Trading Up 1.4 %
NYSE MMS traded up $0.94 on Friday, hitting $68.41. The company's stock had a trading volume of 527,898 shares, compared to its average volume of 548,296. The company's 50-day simple moving average is $67.90 and its 200 day simple moving average is $76.15. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The firm has a market cap of $3.87 billion, a P/E ratio of 14.71 and a beta of 0.68. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.
Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a dividend of $0.30 per share. The ex-dividend date is Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.75%. Maximus's dividend payout ratio is presently 25.81%.
Insider Buying and Selling
In related news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares of the company's stock, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.